Chemiluminescence immunoassay PCT procalcitonin reagents

             Chemiluminescence immunoassay PCT                                            procalcitonin reagents

Product show                                                                               

PCT                                                                                                   

Registration No: Jiangsu food and drug administration 2014-2400660

Initiatedchemiluminescenceperipheralwholoe blood PCT testing, especially recommended for children's hospitals and pediatric outpatient /emergency test. Highaccuracy, recommended to purchase aftercomparison test with Roche.

Clinical significance                                                                  

PCT is a powerful auxiliary tool for infectious diseases diagnosis, stratification, therapy and

prognostic evaluations well as reasonable use of antibiotics. Doctors should raise attention

degree towards PCT test. Start diagnosis and treatment monitoring from patient 

suspected of infectious diseases enter hospital, lay the foundation for the subsequent 

treatment.

PCT Theclinic and emergency application expert consensus - Chinese Journal of Emergency

Medicine (No. 9,Volume 21,September 2012)

CLIA kits description                                                                

Chemiluminescence Immunoassay (CLIA) detection using Microplate luminometers 

provides a sensitive, high throughput, and economical alternative to conventional 

colorimetric methodologies, such as Enzyme-linked immunosorbent assays (ELISA). 

ELISA employs a label enzyme and a colorimetric substrate to produce an amplified signal

for antigen, haptens or antibody quantitation. This technique has been well established and 

considered as the technology of choice for a wide variety of applications in diagnostics, 

research, food testing, process quality assurance and quality control, and environmental

testing. The most commonly used ELISA is based on colorimetric reactions of chromogenic 

substrates, (such as TMB) and label enzymes. 

Recently, a chemiluminescent immunoassay has been shown to be more sensitive than the

conventional colorimetric method(s), and does not require long incubations or the addition

of stopping reagents, as is the case in some colorimetric assays. Among various enzyme 

assays that employ light-emitting reactions, one of the most successful assays is the

enhanced chemiluminescent immunoassay involving a horseradish peroxidase (HRP)

labeled antibody or antigen and a mixture of chemiluminescent substrate, hydrogen 

peroxide, and enhancers. 

Performance analysis                                                               

Correlation analysis of testing result between Norman whole body PCT and Roche PCT

Applicable department                                                            

Pediatrics, ICU, emergency, respiratory, surgical, hospital ward, internal medicine, oncology, hematology

Correlation analysis of testing result between Norman whole body PCT and Biomerieux PCT

Product advantage                                                                     

1.Advanced technology: initiate peripheral whole blood chemiluminescence PCT test

2.High sensitivity: 0.02ng/ml

3.High accuracy:99% correlation with Roche ELECSYS BRAHMS PCT

4.Wide linear range: 0.02 ∽ 100ng/ml

5.Good repeatability: CV≤5%

Company profile                                                                         

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing

of automated chemiluminescence system. Founded in 2008, Norman biological has been 

upholding the idea that R&D shapes future ,and concentration determines success. Ever

since the beginning,Norman has been focusing on developing and manufacturing  

chemiluminescence and immunofluorescence reagents.

Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2

GMP-approved clean workshop. The R&D base, which is over 2,000m2 , is located in state-

level new Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a 

PhD or master's degree.

Powered by advanced technology and excellent talents in the IVD field, Norman has been

consistently improving its innovation platform , and increasing R&D investment. Self-

innovation, combined with long-term strategic cooperation with universities and research

institutes and with outsourced technologies, ensures consistent improvement on product

quality. Norman's R&D field has covered instruments, reagents, and raw materials, and has

been entrusted by the Nanjing government to build a R&D center specialized in biological 

chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.

Being an expert in automated chemiluminescence analysis , Norman owns independent 

and completed intellectual property rights, and its products provide top-notch sensitivity, 

precision and accuracy . Thanks to the self-developed antigens and self-manufactured

antibodies, Norman's products features minimized intra-and inter- batch difference.

After 8 years development, Norman is now on the fast track. An over 30,000m2 global 

R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.

R&D shapes future, and concentration determines success. Driven by the commitment to

"provide complete solution to improve human health", Norman will consistently do its

utmost to drive the IVD industry forward and contribute more to human health.

Agent Wanted                                                                              

If you are interested in working with us, please feel free to contact.

Why us                                                                                            

Manufacturer and Exporter for nearly 10 years with self R&D Research Center;

Professional After-Sale service with On-site support worldwide;

 
CE/ISO13485 Certifications

OEM and ODM are available !